Journal
Cancers
Publication Date
12-17-2025
Volume
17
Issue
24
First Page
4021
Document Type
Open Access Publication
DOI
10.3390/cancers17244021
Rights and Permissions
Bagegni NA, Giridhar KV, Stewart D. HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and Answers. Cancers (Basel). 2025 Dec 17;17(24):4021. doi: 10.3390/cancers17244021 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).
Recommended Citation
Bagegni, Nusayba A; Giridhar, Karthik V; and Stewart, Daphne, "HER2-low and HER2-ultralow metastatic breast cancer and trastuzumab deruxtecan: Common clinical questions and answers." Cancers. 17, 24. 4021 (2025).
https://digitalcommons.wustl.edu/oa_4/6138
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
